Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2026)
Sight Sciences (SGHT) posted quarterly Cash from Financing Activities of $88000.0 for Q1 2026, up 450.0% year-over-year from $16000.0 in Q1 2025, and down 93.04% quarter-over-quarter from $1.3 million in Q4 2025.
Sight Sciences (SGHT) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Sight Sciences' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $88000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 450.0% year-over-year to $88000.0; the TTM figure through Mar 2026 stood at $1.9 million (down 68.54% YoY), while the FY2025 annual figure was $1.8 million, down 63.92% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $88000.0, down from $1.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $5.4 million in Q4 2024, with the low at -$942000.0 in Q1 2024.
- The 5-year median for Cash from Financing Activities is $158000.0 (2022), against an average of $540882.4.
- Peak annual rise in Cash from Financing Activities reached 1333.24% in 2024, while the deepest fall reached 503.85% in 2024.
- Sight Sciences' Cash from Financing Activities stood at $812000.0 in 2022, then tumbled by 53.69% to $376000.0 in 2023, then surged by 1333.24% to $5.4 million in 2024, then sank by 76.53% to $1.3 million in 2025, then plunged by 93.04% to $88000.0 in 2026.
- Business Quant data shows SGHT's Cash from Financing Activities at $88000.0 in Q1 2026, $1.3 million in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Sight Sciences | 449.13 Mn | 369.37 Mn | 21.37 Mn | 474,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 474,000.00 |
| Jun 30, 2026 | 474,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Mar 31, 2026 | 88,000.00 |
| Dec 31, 2025 | 1.27 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 485,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 5.39 Mn |
| Dec 31, 2024 | 5.39 Mn |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Jun 30, 2024 | 441,000.00 |
| Mar 31, 2024 | -942,000.00 |
| Mar 31, 2024 | -942,000.00 |